Quick Answer
Medpace Holdings, Inc. reported Total Revenue of $2.53 billion for the year ending 2025.
- Medpace Holdings, Inc. showed an increase of +20.0% in Total Revenue from 2024 to 2025.
- This data is from Medpace Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 10, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $0.00 | Q1 2017: $106.61 million | Q2 2017: $106.22 million | Q3 2017: $110.64 million | Q4 2017: $112.68 million | Q1 2018: $163.08 million | Q1 2018: $163.08 million | Q2 2018: $170.14 million | Q3 2018: $179.25 million | Q4 2018: $192.12 million | Q1 2019: $200.74 million | Q2 2019: $214.10 million | Q3 2019: $216.24 million | Q4 2019: $229.89 million | Q1 2020: $230.88 million | Q2 2020: $205.00 million | Q3 2020: $230.37 million | Q1 2021: $259.97 million | Q2 2021: $278.29 million | Q3 2021: $295.57 million | Q1 2022: $330.95 million | Q2 2022: $351.21 million | Q3 2022: $383.74 million | Q1 2023: $434.07 million | Q2 2023: $460.87 million | Q3 2023: $492.50 million | Q1 2024: $511.04 million | Q2 2024: $528.10 million | Q3 2024: $533.32 million | Q1 2025: $558.57 million | Q2 2025: $603.31 million | Q3 2025: $659.90 million.
- Over the full 10 years of available data (2016 to 2025), Medpace Holdings, Inc.'s Total Revenue has grown by 500.2%.
- Historical annual values: Fiscal year 2025: $2.53 billion | Fiscal year 2024: $2.11 billion | Fiscal year 2023: $1.89 billion | Fiscal year 2022: $1.46 billion | Fiscal year 2021: $1.14 billion | Fiscal year 2020: $925.93 million | Fiscal year 2019: $860.97 million | Fiscal year 2018: $704.59 million | Fiscal year 2017: $436.15 million | Fiscal year 2016: $421.58 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: